Biosynthesized silver nanoparticles: A step forward for cancer theranostics?

Nanomedicine

Volumn 9, Issue 10, 2014, Pages 1445-1448

  Patra, Chitta Ranjan ^a   Mukherjee, Sudip ^a,b   Kotcherlakota, Rajesh ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

biosynthesis; cancer theranostics; multifunctional activities; nanomedicine; novel treatment strategy; silver nanoparticles; SNP

Indexed keywords

GLUCOSIDE; GOLD NANOPARTICLE; METAL NANOPARTICLE; NANOMATERIAL; OCTACOSANOL; SILVER NANOPARTICLE; SILVER NITRATE; SITOSTEROL; BIOLOGICAL PRODUCT; SILVER;

ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIODEGRADABILITY; BIOSAFETY; BIOSYNTHESIS; CANCER THERAPY; HUMAN; NANOMEDICINE; NONHUMAN; REVIEW; ANIMAL; NEOPLASMS; SYNTHESIS;

ANIMALS; BIOLOGICAL PRODUCTS; HUMANS; METAL NANOPARTICLES; NEOPLASMS; SILVER;

EID: 84907459056     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.89     Document Type: Review

References (21)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA: Cancer J. Clin. 64(1), 9-29 (2014).
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 127(12), 2893-2917 (2010).
3. BCC Research. The global market for cancer therapies will be expected to increase over $110.6 billion by 2013. www.bccresearch.com/pressroom/hlc/global-market-cancer-therapies-expected-increase-$110.6-billion-2013
4. Munger MA, Radwanski P, Hadlock GC, et al. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine 10(1), 1-9 (2014).
5. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38(6), 1759-1782 (2008).
6. Patra CR, Barui AK. Nanoflowers: a future therapy for cardiac and ischemic disease? Nanomedicine (Lond.) 8(11), 1735-1738 (2013).
7. Mukherjee S, Chowdhury D, Kotcherlakota R, et al. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics 4(3), 316-335 (2014).
8. Nanda A, Saravanan M. Biosynthesis of silver nanoparticles from Staphylococcus aureus and its antimicrobial activity against MRSA and MRSE. Nanomedicine 5(4), 452-456 (2009).
9. Nowack B, Krug HF, Height M. 120 years of nanosilver history: implications for policy makers. Environ. Sci. Technol. 45(4), 1177-1183 (2011).
10. Alexander JW. History of the medical use of silver. Surg. Infect. 10(3), 289-292 (2009).
11. Fayaz AM, Balaji K, Girilal M, Yadav R, Kalaichelvan PT, Venketesan R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomedicine 6(1), 103-109 (2010).
12. Amin RM, Mohamed MB, Ramadan MA, Verwanger T, Krammer B. Rapid and sensitive microplate assay for screening the effect of silver and gold nanoparticles on bacteria. Nanomedicine (Lond.) 4(6), 637-643 (2009).
13. Govender R, Phulukdaree A, Gengan RM, Anand K, Chuturgoon AA. Silver nanoparticles of Albizia adianthifolia: the induction of apoptosis in human lung carcinoma cell line. J. Nanobiotechnology 11, 5 (2013).
14. Balachandran YL, Girija S, Selvakumar R, Tongpim S, Gutleb AC, Suriyanarayanan S. Differently environment stable bio-silver nanoparticles: study on their optical enhancing and antibacterial properties. PLoS ONE 8(10), e77043 (2013).
15. Homan KA, Souza M, Truby R, et al. Silver nanoplate contrast agents for in vivo molecular photoacoustic imaging. ACS Nano 6(1), 641-650 (2012).
16. Stensberg MC, Wei Q, McLamore ES, Porterfield DM, Wei A, Sepulveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond.) 6(5), 879-898 (2011).
17. Hackenberg S, Scherzed A, Kessler M, et al. Silver nanoparticles: evaluation of DNA damage, toxicity and functional impairment in human mesenchymal stem cells. Toxicol. Lett. 201(1), 27-33 (2011).
18. van Aerle R, Lange A, Moorhouse A, et al. Molecular mechanisms of toxicity of silver nanoparticles in zebrafish embryos. Environ. Sci. Technol. 47(14), 8005-8014 (2013).
19. Zhou C, Long M, Qin Y, Sun X, Zheng J. Luminescent gold nanoparticles with efficient renal clearance. Angew. Chem. Int. Ed. Engl. 50(14), 3168-3172 (2011).
20. de Lima R, Seabra AB, Duran N. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J. Appl. Toxicol. 32(11), 867-879 (2012).
21. He Y, Du Z, Lv H, et al. Green synthesis of silver nanoparticles by Chrysanthemum morifolium Ramat. extract and their application in clinical ultrasound gel. Int. J. Nanomedicine 8, 1809-1815 (2013).